Express Scripts (ESRX) weekly volatility increases into Q2 and outlook

Go back to Express Scripts (ESRX) weekly volatility increases into Q2 and outlook

Jefferies Cuts Price Target on Express Scripts (ESRX) to $88 Following 2Q Report

July 26, 2016 9:22 AM EDT

Jefferies maintained a Buy rating on Express Scripts (NASDAQ: ESRX), and cut the price target to $88.00 (from $98.00), following the company's 2Q earnings report. ESRX's volumes were slightly below expectations at 315MM, but in-line results should offset this 1% shortfall.

Analyst Brian Tanquilut commented,... More

FBR Capital Remains Sidelined on Express Scripts (ESRX) Following 2Q Report

July 26, 2016 6:54 AM EDT

FBR Capital reiterated a Market Perform rating and $75.00 price target on Express Scripts (NASDAQ: ESRX) following the company's 2Q earnings report. ESRX reported revenue of $25.3 billion, slightly below consensus estimates of $25.4 billion. Adjusted EPS grew 9.3% to $1.57.

Analyst Steven Halper commented, "After the close on July 25, Express... More

Express Scripts (ESRX) Reports In-Line Q2 EPS; Boosts FY16 EPS Outlook

July 25, 2016 4:02 PM EDT

Express Scripts (NASDAQ: ESRX) reported Q2 EPS of $1.57, in-line with the analyst estimate of $1.57. Revenue for the quarter came in at $25.2 billion versus the consensus estimate of $25.42 billion.

GUIDANCE:

Express Scripts sees FY2016 EPS of $6.33-$6.43, versus prior guidance of... More